WONDFO BIOTECH(SZ:300482) Zheng Quan Zhi Xing·2025-06-18 09:28Core Viewpoint - Guangzhou Wanfu Biological Technology Co., Ltd. has decided to terminate the implementation of the 2024 restricted stock incentive plan and to repurchase and cancel the restricted stocks involved in the plan due to significant changes in the internal and external business environment, which have led to discrepancies between expected operational conditions and the assessment criteria set in the incentive plan [1][8]. Group 1: Authorization and Approval - The company has completed necessary procedures for the termination and repurchase, including resolutions from the board of directors and supervisory board, and has disclosed relevant announcements [4][8]. - The company’s supervisory board did not receive any objections during the public notice period regarding the list of incentive objects [5]. Group 2: Specifics of Termination and Repurchase - The company will repurchase a total of 10.544 million shares of restricted stock, which were granted but not yet released from restrictions [8]. - The repurchase price is set at 12.42 yuan per share plus the interest from bank deposits at the same period [8]. - The funding for the repurchase will come from the company's own funds [8]. Group 3: Legal Compliance and Impact - The termination and repurchase comply with relevant laws and regulations, including the Company Law and Securities Law, and will not significantly impact the company's operations or shareholder rights [9].